Merck signs up to $3.3 billion cancer drug deal with China-based LaNova
(Reuters) -Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and sell an experimental cancer drug, the two companies said on ...
Pharmabiz9h
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million: Boston, Massachusetts Thursday, ...
Pharmabiz1d
Merck to present new data from Gardasil 9 studies reinforcing the importance of gender-neutral HPV vaccination in adults up to age 45 at IPVC 2024
Rahway, New Jersey Wednesday, November 13, 2024, 13:00 Hrs [IST] ...
China Internet Information Center3dOpinion
CIIE advances China's high-quality opening up
As the world's first national-level import-themed trade exhibition, the CIIE provides strong evidence of China's opening up ...
China Internet Information Center6d
Global medical giants tapping Chinese market at import expo
With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...